U.S. markets open in 4 hours 26 minutes

ResMed Inc. (RMD)

NYSE - NYSE Delayed Price. Currency in USD
157.73-1.12 (-0.71%)
At close: 04:00PM EST
157.56 -0.17 (-0.11%)
Pre-Market: 04:27AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Up

Gap Up

Previous Close158.85
Bid0.00 x 800
Ask166.45 x 900
Day's Range156.67 - 160.16
52 Week Range132.24 - 243.52
Avg. Volume1,605,891
Market Cap23.201B
Beta (5Y Monthly)0.52
PE Ratio (TTM)25.65
EPS (TTM)6.15
Earnings DateJan 24, 2024 - Jan 29, 2024
Forward Dividend & Yield1.92 (1.22%)
Ex-Dividend DateNov 08, 2023
1y Target Est178.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ResMed Inc.
    RMD: Raising target price to $125.00RESMED INC has an Investment Rating of SELL; a target price of $125.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more